Annals of Breast Cancer and Therapy

Dr. Wael M ElShamy

Associate Professor
Department of Radiation Oncology and Pathology
University of Mississippi
United States of America
Tel: 601-815-6814

Dr. Wael M. ElShamy graduated from the Department of Chemistry in Ayn-Shams University, Egypt in 1986. He later obtained two master degrees in Biochemistry and Molecular Biology from Stockholm University, Sweden and a Ph.D. in Medical Biochemistry and Biophysics from Royal Karolinska Institute, Stockholm, Sweden. In 1998, he moved to Dana-Farber Cancer Institute and Harvard Medical School for a Postdoctoral fellowship and later became an instructor in Harvard Medical School. He is Dr. Lawrence and Mrs. Bo Hing chan Tseu American Cancer Society Research Scholar. In 2011, Dr. ElShamy became the Director of Molecular Cancer Therapeutics program, Cancer institute, University of Mississippi Medical Center. He is a Principal Investigator and Co-Investigator on several grants. Dr. ElShamy’ s interests encompass basic, clinical and translational cancer research. Research programs in his laboratory and program focus on identifying and improve treatments for breast and ovarian cancers, especially metastatic diseases, development of novel drug delivery techniques and identifying diagnostic as well as prognostic molecular biomarkers for these diseases. In his laboratory, the main focus is identifying the earliest disease lesions, and the development of targeted therapies for cancer stem cells.